Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Ad/Promo Crackdown Letters Came From OPDP Staff, Not Artificial Intelligence
Oct 17 2025
•
By
Sue Sutter
A former OPDP official worries about intellectual property protections for ad/promo submissions to the FDA.
(Shutterstock)
More from Marketing & Advertising
More from United States